Effect of a Specific Hand Intervention in Women With Arthralgia Secondary to Hormone Therapy Following Breast Cancer.

Launched by UNIVERSIDAD EUROPEA DE MADRID · Dec 17, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how a special hand exercise program can help women who are experiencing joint pain in their hands due to hormone therapy after breast cancer treatment. Over 12 weeks, participants will either take part in the exercise program or not do any exercises at all. The researchers want to see if those who do the hand exercises report less pain and improved ability to use their hands in daily activities.

To be eligible for this study, women must be experiencing pain in their hands caused by hormone therapy, like aromatase inhibitors or tamoxifen, after their breast cancer treatment. They should be able to express their pain levels and follow simple instructions. However, if someone is taking medications that could change their pain levels, or if they have certain other conditions, they won't be able to participate. This trial is not yet recruiting participants, but it aims to offer insights into whether targeted hand exercises can make a real difference in the lives of these women.

Gender

FEMALE

Eligibility criteria

• • Inclusion Criteria
• • Experiencing hand arthralgia as a result of hormone therapy (aromatase inhibitors or tamoxifen) following breast cancer.
• • Ability to communicate pain levels effectively. Ability to follow simple instructions to participate in the intervention and assessments.
• • Exclusion Criteria Participants requiring any medication changes during the study period that could influence pain levels (increase or decrease).
• • Concurrent physiotherapy or occupational therapy specifically targeting the hand during the study.
• • Pre-existing diagnosis of arthritis or osteoarthritis in the hand before starting hormone therapy.
• • Presence of systemic diseases associated with hand arthralgia. Neurological conditions affecting hand movement.